185 related articles for article (PubMed ID: 27079922)
1. Comparisons of parallel potential biomarkers of 1H-MRS-measured hepatic lipid content in patients with non-alcoholic fatty liver disease.
Shih KL; Su WW; Chang CC; Kor CT; Chou CT; Chen TY; Wu HM
Sci Rep; 2016 Apr; 6():24031. PubMed ID: 27079922
[TBL] [Abstract][Full Text] [Related]
2. Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histology.
Calvo N; Beltrán-Debón R; Rodríguez-Gallego E; Hernández-Aguilera A; Guirro M; Mariné-Casadó R; Millá L; Alegret JM; Sabench F; del Castillo D; Vinaixa M; Rodríguez MÀ; Correig X; García-Álvarez R; Menendez JA; Camps J; Joven J
World J Gastroenterol; 2015 Jun; 21(24):7529-44. PubMed ID: 26140000
[TBL] [Abstract][Full Text] [Related]
3. Ultra-high-field magnetic resonance spectroscopy in non-alcoholic fatty liver disease: Novel mechanistic and diagnostic insights of energy metabolism in non-alcoholic steatohepatitis and advanced fibrosis.
Traussnigg S; Kienbacher C; Gajdošík M; Valkovič L; Halilbasic E; Stift J; Rechling C; Hofer H; Steindl-Munda P; Ferenci P; Wrba F; Trattnig S; Krššák M; Trauner M
Liver Int; 2017 Oct; 37(10):1544-1553. PubMed ID: 28544208
[TBL] [Abstract][Full Text] [Related]
4. Validation of water-fat MRI and proton MRS in assessment of hepatic fat and the heterogeneous distribution of hepatic fat and iron in subjects with non-alcoholic fatty liver disease.
Hui SCN; So HK; Chan DFY; Wong SKH; Yeung DKW; Ng EKW; Chu WCW
Eur J Radiol; 2018 Oct; 107():7-13. PubMed ID: 30292275
[TBL] [Abstract][Full Text] [Related]
5. Non-invasive assessment of hepatic lipid subspecies matched with non-alcoholic fatty liver disease phenotype.
Erickson ML; Haus JM; Malin SK; Flask CA; McCullough AJ; Kirwan JP
Nutr Metab Cardiovasc Dis; 2019 Nov; 29(11):1197-1204. PubMed ID: 31371265
[TBL] [Abstract][Full Text] [Related]
6. [Value of hydrogen proton magnetic resonance spectroscopy in the determination of liver triglyceride in patients with fatty liver disease and its influencing factors].
Qu HJ; Wang L; Jin PH; Gao Q; Zhou JX; Song Y; Wang J; Jiang YM; Gong L; Chen GY; Ding JP; Shi JP
Zhonghua Gan Zang Bing Za Zhi; 2017 Nov; 25(11):858-863. PubMed ID: 29325281
[No Abstract] [Full Text] [Related]
7. Efficacy of the Omega-3 Index in predicting non-alcoholic fatty liver disease in overweight and obese adults: a pilot study.
Parker HM; O'Connor HT; Keating SE; Cohn JS; Garg ML; Caterson ID; George J; Johnson NA
Br J Nutr; 2015 Sep; 114(5):780-7. PubMed ID: 26202539
[TBL] [Abstract][Full Text] [Related]
8. Non-alcoholic fatty liver disease and subclinical atherosclerosis: A comparison of metabolically- versus genetically-driven excess fat hepatic storage.
Di Costanzo A; D'Erasmo L; Polimeni L; Baratta F; Coletta P; Di Martino M; Loffredo L; Perri L; Ceci F; Montali A; Girelli G; De Masi B; Angeloni A; Catalano C; Maranghi M; Del Ben M; Angelico F; Arca M
Atherosclerosis; 2017 Feb; 257():232-239. PubMed ID: 28027788
[TBL] [Abstract][Full Text] [Related]
9. Low hepatic copper content and PNPLA3 polymorphism in non-alcoholic fatty liver disease in patients without metabolic syndrome.
Stättermayer AF; Traussnigg S; Aigner E; Kienbacher C; Huber-Schönauer U; Steindl-Munda P; Stadlmayr A; Wrba F; Trauner M; Datz C; Ferenci P
J Trace Elem Med Biol; 2017 Jan; 39():100-107. PubMed ID: 27908400
[TBL] [Abstract][Full Text] [Related]
10. [Quantitative assessment of intrahepatic fat content in children and adolescents with non-alcoholic fatty liver disease].
Zhang HX; Fu JF; Huang K; Lai C; Liang L; Jiang KW
Zhongguo Dang Dai Er Ke Za Zhi; 2012 Aug; 14(8):598-603. PubMed ID: 22898281
[TBL] [Abstract][Full Text] [Related]
11. MRI-determined liver fat correlates with risk of metabolic syndrome in patients with nonalcoholic fatty liver disease.
Chen J; Duan S; Ma J; Wang R; Chen J; Liu X; Xue L; Xie S; Yao S
Eur J Gastroenterol Hepatol; 2020 Jun; 32(6):754-761. PubMed ID: 32091437
[TBL] [Abstract][Full Text] [Related]
12. Association of epicardial fat volume and nonalcoholic fatty liver disease with metabolic syndrome: From the CAESAR study.
Kim BJ; Kim HS; Kang JG; Kim BS; Kang JH
J Clin Lipidol; 2016; 10(6):1423-1430.e1. PubMed ID: 27919360
[TBL] [Abstract][Full Text] [Related]
13. Associations between Dietary Nutrient Intakes and Hepatic Lipid Contents in NAFLD Patients Quantified by ¹H-MRS and Dual-Echo MRI.
Cheng Y; Zhang K; Chen Y; Li Y; Li Y; Fu K; Feng R
Nutrients; 2016 Aug; 8(9):. PubMed ID: 27618908
[TBL] [Abstract][Full Text] [Related]
14. External validation of the fatty liver index and lipid accumulation product indices, using 1H-magnetic resonance spectroscopy, to identify hepatic steatosis in healthy controls and obese, insulin-resistant individuals.
Cuthbertson DJ; Weickert MO; Lythgoe D; Sprung VS; Dobson R; Shoajee-Moradie F; Umpleby M; Pfeiffer AF; Thomas EL; Bell JD; Jones H; Kemp GJ
Eur J Endocrinol; 2014 Nov; 171(5):561-9. PubMed ID: 25298375
[TBL] [Abstract][Full Text] [Related]
15. Mass-Spectrometry-Based Serum Metabolomics of a C57BL/6J Mouse Model of High-Fat-Diet-Induced Non-alcoholic Fatty Liver Disease Development.
Lai YS; Chen WC; Kuo TC; Ho CT; Kuo CH; Tseng YJ; Lu KH; Lin SH; Panyod S; Sheen LY
J Agric Food Chem; 2015 Sep; 63(35):7873-84. PubMed ID: 26262841
[TBL] [Abstract][Full Text] [Related]
16. Serum biomarkers combined with ultrasonography for early diagnosis of non-alcoholic fatty liver disease confirmed by magnetic resonance spectroscopy.
Qian LL; Wu L; Zhang L; Zhang J; Zhou J; Li YH; Fang QC; Li HT; Jia WP
Acta Pharmacol Sin; 2020 Apr; 41(4):554-560. PubMed ID: 31776449
[TBL] [Abstract][Full Text] [Related]
17. NAFLD in clinical practice: Can simple blood and anthropometric markers be used to detect change in liver fat measured by
Keating SE; Parker HM; Hickman IJ; Gomersall SR; Wallen MP; Coombes JS; Macdonald GA; George J; Johnson NA
Liver Int; 2017 Dec; 37(12):1907-1915. PubMed ID: 28581252
[TBL] [Abstract][Full Text] [Related]
18. In vivo and ex vivo measurements: noninvasive assessment of alcoholic fatty liver using 1H-MR spectroscopy.
Keese D; Korkusuz H; Huebner F; Namgaladze D; Raschidi B; Vogl TJ
Diagn Interv Radiol; 2016; 22(1):13-21. PubMed ID: 26627137
[TBL] [Abstract][Full Text] [Related]
19. Hepatic Alanine Differentiates Nonalcoholic Steatohepatitis From Simple Steatosis in Humans and Mice: A Proton MR Spectroscopy Study With Long Echo Time.
Kim TH; Jun HY; Kim KJ; Lee YH; Lee MS; Choi KH; Yun KJ; Jeong YY; Jun CH; Cho EY; Yoon KH
J Magn Reson Imaging; 2017 Nov; 46(5):1298-1310. PubMed ID: 28225569
[TBL] [Abstract][Full Text] [Related]
20. A comparison of liver fat content as determined by magnetic resonance imaging-proton density fat fraction and MRS versus liver histology in non-alcoholic fatty liver disease.
Idilman IS; Keskin O; Celik A; Savas B; Elhan AH; Idilman R; Karcaaltincaba M
Acta Radiol; 2016 Mar; 57(3):271-8. PubMed ID: 25855666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
